亚太电生理测绘和消融设备市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太电生理测绘和消融设备市场 – 行业趋势和 2030 年预测

  • Healthcare
  • Upcoming Report
  • Jan 2023
  • Asia-Pacific
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Asia Pacific Electrophysiology Mapping And Ablation Devices Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 2,180.36 Million
Diagram Market Size (Forecast Year)
USD 4,917.10 Million
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

亚太电生理映射和消融设备市场,按类型(消融设备和电生理映射)、适应症(心脏病学、癌症、整容手术、妇科、肿瘤学、眼科、骨科治疗、疼痛管理、泌尿科、心房扑动、房室结折返性心动过速 (AVNRT)、心房颤动、沃尔夫-帕金森-怀特综合征 (WPW) 等)、功能(常规。高级、冷冻消融、微波和超声波)、程序(美学-皮肤年轻化和紧致、美学-身体塑形、脂肪减少和橘皮组织外观的最小化、良性前列腺增生、经尿道针消融、激光和其他基于能量的疗法/钬激光消融/前列腺剜除术、压力性尿失禁,月经过多/子宫内膜消融、子宫肌瘤、脊柱减压和去神经支配、静脉曲张、心房颤动、肿瘤消融等)、最终用户(医院、门诊手术中心、诊断中心、心导管实验室、专科诊所等)——行业趋势和预测到 2030 年。

亚太电生理测绘及消融设备市场

亚太电生理映射和消融设备市场分析和规模

根据 ELSO 的数据,2018 年全球有近 500 万人患有房颤。其中,200 万人确诊,100 万人被误诊,估计死亡率分别为 3% 和 6%。电生理标测和消融设备用于治疗各种心律失常,如心房颤动、室性早搏 (PVC)、心房扑动、房室结折返性心动过速等。2017 年,PVC 行业的销售额市场份额为 29.0%,占据行业主导地位。当年,PVC 行业领先于其他应用类别的关键因素之一是高血压患者中 PVC 的患病率很高。

Data Bridge Market Research 分析,电生理测绘和消融设备市场在 2022 年的规模为 21.8036 亿美元,预计到 2030 年将达到 49.171 亿美元,在 2023 年至 2030 年的预测期内复合年增长率为 10.7%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

亚太电生理映射和消融设备市场范围和细分      

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(百万美元)、销量(单位)、定价(美元)

涵盖的领域

Type (Ablation Devices and Electrophysiology Mapping), Indication (Cardiology, Cancer, Cosmetic Surgery, Gynecology, Oncology, Ophthalmology, Orthopedic Treatment, Pain Management, Urology, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia (AVNRT), Atrial Fibrillation, Wolff-Parkinson-White Syndrome (WPW) and Others), Function (Conventional. Advanced, Cryoablation, Microwave and Ultrasound), Procedure (Aesthetics-Skin Rejuvenation and Tightening, Aesthetics-Body Sculpting, Fat Reduction, and The Minimization In The Appearance Of Cellulite, Benign Prostatic Hyperplasia, Transurethral Needle Ablation, Laser And Other Energy-Based Therapies/Holmium Laser Ablation/Enucleation of The Prostate, Stress Urinary Incontinence, Menorrhagia/Endometrial Ablation, Uterine Fibroids, Spinal Decompression And Denervation, Varicose Veins, Atrial Fibrillation, Tumor Ablation and Others), End-User (Hospitals, Ambulatory Surgery Center, Diagnostic Center, Cardiac Catheterization Laboratories, Specialty Clinics and Others)

Countries Covered

China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)

Market Players Covered

Abbott (U.S.), Arthrex, Inc. (U.S.), TORAY INDUSTRIES, INC. (U.S.), Olympus Corporation (Japan), Teleflex Incorporated (U.S.), MicroPort Scientific Corporation (China), BIOTRONIK SE & Co. KG. (Germany), Boston Scientific Corporation (U.S.), GE Healthcare (U.S.), Siemens Healthineers AG (Germany), Japan Lifeline Co., Ltd. (Japan), STARmed Co., Ltd. (South Korea), Koninklijke Philips N.V. (Netherlands), Surgnova (China), Medtronic (Ireland)

Market Opportunities

Growing demand for minimally invasive procedures

Market Definition

The technique of electrophysiology mapping is used to identify the electrical impulses of the heart. The equipment used for mapping electrophysiology, which computes or maps the electrical activity of the heart. Furthermore, these tools are frequently utilised to treat patients with cardiac rhythm issues such arrhythmias and many other heart-related illnesses. Ablation devices are frequently used to treat the defective heart tissue that can result in arrhythmias like atrial flutter and atrial fibrillation as well as other chronic diseases like lung, liver, prostate, and kidney cancer. In order to treat patients, ablation devices generate heat using energy, laser, microwave, and radiofrequency.

Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Dynamics

Drivers

  • Increasing incidence of cardiac arrhythmias

The global prevalence of cardiac arrhythmias is high, with an estimated 2-3% of the general population suffering from them. This figure is expected to rise in the future due to a variety of factors including an ageing population, rising obesity and diabetes rates, and increased exposure to environmental stressors. This will result in a large number of patients requiring electrophysiology mapping and ablation devices for treatment.

Opportunities

  • Growing demand for minimally invasive procedures

Minimally invasive procedures are in high demand across all medical specialties due to their numerous advantages over traditional surgery, such as reduced pain, shorter hospital stay, faster recovery time, and among others. Electrophysiology mapping and ablation devices are ideal for use in minimally invasive procedures because of their small size and portability. This will help them expand in the coming years.

Restraints/Challenges

  • High cost

In developing and underdeveloped economies, improper and unfavourable reimbursement scenarios will hamper the market growth. Furthermore, the high costs associated with electrophysiology products will present additional challenges to the market. Stringent regulatory standards will also slow market growth. The price of an EP recording system is USD 160,000. EP procedures are generally expensive due to high capital, training, and maintenance costs. A catheter ablation procedure, for example, typically costs between USD 4,000 and $6,500.

This electrophysiology mapping and ablation devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the electrophysiology mapping and ablation devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2020, Siemens Healthineers AG introduced the ACUSON Redwood Ultrasound System in India. This cutting-edge device has numerous uses in cardiology mapping and identifies and diagnoses lesions. by expanding its line of products and stimulating the market for electrophysiology mapping and ablation devices in the Asia-Pacific region.
  • In 2019, Medtronic acquired EPIX Therapeutics, Inc. to expand its product portfolio. EPIX Therapeutics, Inc is developing catheter-based, temperature-controlled cardiac ablation devices to treat patients with cardiac arrhythmias such as atrial fibrillation.

Asia-Pacific Electrophysiology Mapping and Ablation Devices Market Scope

电生理学映射和消融设备市场根据类型、适应症、功能、程序和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

类型

  • 消融设备
  • 电生理映射

指征

  • 心脏病学
  • 癌症
  • 整形外科
  • 妇科
  • 肿瘤学
  • 眼科
  • 骨科治疗
  • 疼痛管理
  • 泌尿科
  • 心房扑动
  • 房室结折返性心动过速 (AVNRT)
  • 心房颤动
  • 沃夫-帕金森-怀特综合征 (WPW)
  • 其他的

 功能

  • 传统的
  • 先进的
  • 冷冻消融
  • 微波
  • 超声波

 程序

  • 美学-皮肤嫩肤
  • 紧缩
  • 美学塑身
  • 减脂
  • 减少橘皮组织的出现
  • 良性前列腺增生
  • 经尿道针刺消融术
  • 激光
  • 其他基于能量的疗法/钬激光消融/前列腺剜除术
  • 压力性尿失禁
  • 月经过多/子宫内膜消融
  • 子宫肌瘤
  • 脊柱减压和去神经支配
  • 静脉曲张
  • 心房颤动
  • 肿瘤消融
  • 其他的

 终端用户

  • 医院
  • 门诊手术中心
  • 诊断中心
  • 心导管实验室
  • 专科诊所
  •  其他的

电生理映射和消融设备市场区域分析/见解

对电生理映射和消融设备市场进行了分析,并按国家、类型、适应症、功能、程序和最终用户提供了市场规模见解和趋势。

电生理测绘和消融设备市场报告涵盖的国家包括亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 其他地区

在亚太地区,日本由于在射频消融器和电生理标测和消融设备市场研发力度加大,在亚太电生理标测和消融设备市场占据主导地位。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

电生理映射和消融设备市场还为您提供每个国家/地区资本设备医疗保健支出增长、电生理映射和消融设备市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对电生理映射和消融设备市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。

竞争格局和电生理测绘及消融设备市场份额分析

电生理映射和消融设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对电生理映射和消融设备市场的关注有关。

电生理映射和消融设备市场的一些主要参与者包括:

  • 雅培(美国)
  • Arthrex, Inc.(美国)
  • 东丽工业公司(美国)
  • 奥林巴斯株式会社(日本)
  • Teleflex Incorporated(美国)
  • 微创医疗科学有限公司 (中国)
  • 百多力股份公司。 (德国)
  • 波士顿科学公司 (美国)
  • GE医疗(美国)
  • 西门子医疗股份公司(德国)
  • 日本生命线株式会社(日本)
  • STARmed 有限公司 (韩国)
  • Koninklijke Philips NV(荷兰)
  • Surgnova(中国)
  • 美敦力(爱尔兰)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Asia-Pacific Electrophysiology Mapping and Ablation Devices Market size will be worth USD 4917.10 million by 2030 during the forecast period.
The Asia-Pacific Electrophysiology Mapping and Ablation Devices Market growth rate is 10.7% during the forecast period.
The Increasing incidence of cardiac arrhythmias is the growth driver of the Asia-Pacific Electrophysiology Mapping and Ablation Devices Market.
The type, indication, function, procedure and end user are the factors on which the Asia-Pacific Electrophysiology Mapping and Ablation Devices Market research is based.
The major companies in the Asia-Pacific Electrophysiology Mapping and Ablation Devices Market are Abbott (U.S.), Arthrex, Inc. (U.S.), TORAY INDUSTRIES, INC. (U.S.), Olympus Corporation (Japan), Teleflex Incorporated (U.S.), MicroPort Scientific Corporation (China), BIOTRONIK SE & Co. KG. (Germany), Boston Scientific Corporation (U.S.), GE Healthcare (U.S.), Siemens Healthineers AG (Germany), Japan Lifeline Co., Ltd. (Japan), STARmed Co., Ltd. (South Korea), Koninklijke Philips N.V. (Netherlands), Surgnova (China), Medtronic (Ireland).